Related references
Note: Only part of the references are listed.Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?
Vera E. Valkhoff et al.
BMC PEDIATRICS (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Stroke risk and NSAIDs: a systematic review of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs A Nationwide Case-Crossover Study
Chia-Hsuin Chang et al.
STROKE (2010)
Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke
Christianne L. Roumie et al.
STROKE (2008)
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke - A nested case-control study
Frank Andersohn et al.
STROKE (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors
Linda E. Levesque et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk of stroke associated with nonsteroidal anti-inflammatory drugs -: A nested case-control study
S Bak et al.
STROKE (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
WA Ray et al.
LANCET (2002)
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction
DH Solomon et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Non-steroidal anti-inflamatory drugs and risk of serious coronary heart disease: an observational cohort study
WA Ray et al.
LANCET (2002)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation -: An overview of epidemiologic studies published in the 1990s
S Hernández-Díaz et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women
LAG Rodríguez et al.
EPIDEMIOLOGY (2000)